NASEM Substandard And Falsified Medical Products Workshop
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 923120 Administration of Public Health Programs
- Points of contact
-
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is planning a public workshop led by the National Academies of Sciences, Engineering, and Medicine (NASEM) focused on addressing substandard and falsified (SF) medical products. The forecasted contract opportunity is scheduled for solicitation release on July 1, 2026, with an estimated award date of September 1, 2026, categorized under Administration of Public Health Programs (NAICS 923120). The workshop aims to explore and develop strategies for mitigating risks associated with substandard and falsified medical products.
The specific details regarding award values, budget ranges, and precise service quantities are currently not available in the forecast. The point of contact for this opportunity is Joshua Holliday, who can be reached at joshua.holliday@fda.hhs.gov within the FDA organization. As the opportunity is still in the forecast stage, interested parties should monitor future solicitation documents for more comprehensive information about the workshop's scope, potential vendor requirements, and specific performance expectations.
Forecast text
Public workshop led by the National Academies of Sciences, Engineering, and Medicine (NASEM) to address the continuing problem of substandard and falsified (SF) medical products.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast